Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Report

Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 05, 2022
  • PAGES：161
  • REPORT CODE：GMM1347592
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.

    This report elaborates on the current development of the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Emergent BioSolutions Inc

    • Johnson & Johnson

    • Astellas Pharma US, Inc

    • AstraZeneca

    • GlaxoSmithKline

    • Novartis AG

    • Seqirus

    • Protein Sciences Corporation

    • Merck Sharp & Dohme Corp

    • Sanofi Pasteur

    • Lanzhou Institute of Biological Products Co, Ltd

    • Pfizer Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Immune DTaP Vaccine

    • Therapy DTaP Vaccine

    Application:

    • Adult

    • Pediatric

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Overview

      • 1.1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Scope and Market Segments

      • 1.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Characteristics

      • 1.1.3 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Immune DTaP Vaccine

      • 1.2.2 Therapy DTaP Vaccine

    • 1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Adult

      • 1.3.2 Pediatric

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry PEST Analysis

    • 2.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry

    Chapter 3 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Manufacturer

    • 3.1 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Top 3 Players

    Chapter 4 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Type (2017-2028)

    • 4.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Trend, by Type

    • 4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis

    • 7.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Type

    • 7.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Application

    • 7.3 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis

    • 8.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Type

    • 8.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Application

    • 8.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis

    • 9.1 APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Type

    • 9.2 APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Application

    • 9.3 APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Company Profiles

      • 11.1 Emergent BioSolutions Inc

        • 11.1.1 Emergent BioSolutions Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.1.3 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Johnson & Johnson

        • 11.2.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.2.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Astellas Pharma US, Inc

        • 11.3.1 Astellas Pharma US, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.3.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 AstraZeneca

        • 11.4.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.4.3 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 GlaxoSmithKline

        • 11.5.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.5.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis AG

        • 11.6.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.6.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Seqirus

        • 11.7.1 Seqirus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.7.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Protein Sciences Corporation

        • 11.8.1 Protein Sciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.8.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Merck Sharp & Dohme Corp

        • 11.9.1 Merck Sharp & Dohme Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.9.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Sanofi Pasteur

        • 11.10.1 Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.10.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Lanzhou Institute of Biological Products Co, Ltd

        • 11.11.1 Lanzhou Institute of Biological Products Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Lanzhou Institute of Biological Products Co, Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.11.3 Lanzhou Institute of Biological Products Co, Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Pfizer Inc

        • 11.12.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Profiles, Application and Specification

        • 11.12.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Immune DTaP Vaccine (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Therapy DTaP Vaccine (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Adult (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Pediatric (2017-2028)

    • Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share, by Manufacturer in 2022

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Type (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value, by Type (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend, by Type (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Type (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value, by Type (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend, by Type (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Application (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value, by Application (2017-2028)

    • Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value Share, by Application (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Application (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value, by Application (2017-2028)

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Type (2017-2028)

    • Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Application (2017-2028)

    • Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Emergent BioSolutions Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emergent BioSolutions Inc Product Profiles, Application and Specification

    • Table Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma US, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma US, Inc Product Profiles, Application and Specification

    • Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Seqirus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Seqirus Product Profiles, Application and Specification

    • Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Protein Sciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Protein Sciences Corporation Product Profiles, Application and Specification

    • Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Sharp & Dohme Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Sharp & Dohme Corp Product Profiles, Application and Specification

    • Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur Product Profiles, Application and Specification

    • Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lanzhou Institute of Biological Products Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lanzhou Institute of Biological Products Co, Ltd Product Profiles, Application and Specification

    • Table Lanzhou Institute of Biological Products Co, Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc Product Profiles, Application and Specification

    • Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US